(1)
Prima Sanjiwani Saraswati Sudarsa; Mario Korwa; Nyoman Suryawati. Therapeutic Outcomes of Secukinumab 300 Mg in Severe Psoriasis Vulgaris With Metabolic Comorbidities: A Retrospective Cohort Study in Bali. Bioscmed 2026, 10, 1048-1096.